Zobrazeno 1 - 2
of 2
pro vyhledávání: '"David Kharshiladze"'
Autor:
Tamar Kikvidze, Konstantine Labartkava, Niklas Luhmann, George Kamkamidze, Aurélie Etienne, Julie Bouscaillou, Elisabeth Avril, David Kharshiladze, Diane Le Pluart, Ina Inaridze, Maia Butsashvili, Ana Gamezardashvili
Publikováno v:
International Journal of Drug Policy. 62:104-111
Background People who inject drugs (PWID) are often excluded from HCV treatment programs due to concerns about their ability to adhere to care. Georgia has a high prevalence of HCV infection (5.4% of chronic cases in general population) with an epide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87dfc8f3af7b589905d9c6baeec2fc57
https://doi.org/10.1016/j.drugpo.2018.07.016
https://doi.org/10.1016/j.drugpo.2018.07.016
Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia
Autor:
Konstantine Labartkava, Elisabeth Avril, Maia Butsashvili, Niklas Luhmann, Tamar Kikvidze, David Kharshiladze, Julie Bouscaillou, Aurélie Etienne, Diane Le Pluart, Ina Inaridze, Ana Gamezardashvili
Publikováno v:
International Journal of Drug Policy. 52:16-19
Backgrounds Georgia faces high HCV rates (5.4% of chronic cases in general population) with an epidemic concentrated among people who inject drugs (PWID). A National HCV Elimination Program (NHCEP), was launched in April 2015, aiming to eliminate HCV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a6d093ea242bf86d55b9930d33a0d4e
https://doi.org/10.1016/j.drugpo.2017.11.014
https://doi.org/10.1016/j.drugpo.2017.11.014